U.S. stocks extended losses toward the end of trading, with the Dow Jones dropping to a fresh low for the year.
The Dow traded down 2.48% to 29,331.80 while the NASDAQ fell 2.78% to 10,759.32. The S&P 500 also fell, dropping, 2.67% to 3,657.63.
Also check this: Ethereum Rises Above This Major Level, Here Are Other Crypto Movers That Should Be On Your Radar Today
Leading and Lagging Sectors
Health care shares fell by just 1.5% on Friday.
In trading on Friday, energy shares dipped by 7.2%.
Top Headline
The S&P Global services PMI climbed to 49.2 in September from 43.7 in the prior month, while manufacturing PMI rose to 51.8 in September from 51.5 in August.
Equities Trading UP
- Snow Lake Resources Ltd. LITM shares shot up 42% to $3.2750 following news the company will collaborate with an LG unit to form a North American supply chain for lithium.
- Shares of Athersys, Inc. ATHX got a boost, shooting 36% to $1.5911 after the company announced it entered into amended agreements to extend the exercise period of the warrants that were issued as part of a recent registered direct offering.
- Sonendo, Inc. SONX shares were also up, gaining 21% to $1.10. Sonendo announced a private placement of common stock and pre-funded warrants, resulting in gross proceeds of $63 million led by a consortium of new and existing investors.
Equities Trading DOWN
- Avenue Therapeutics, Inc. ATXI shares tumbled 37% to $4.1501 after the company received the official meeting minutes from the FDA regarding a meeting conducted for IV Tramadol in combination with other opioid analgesics to manage moderate-to-moderately severe pain. Concurrently, Avenue Therapeutics announced that it would effect a 1-for-15 reverse stock split.
- Shares of Splash Beverage Group, Inc. SBEV were down 28% to $1.39 after the company announced pricing of a $3.1 million public offering of 2 million shares of common stock at $1.55 per share.
- Spectrum Pharmaceuticals, Inc. SPPI was down, falling 33% to $0.4234 after the FDA Oncologic Drugs Advisory Committee voted 9-4 that the current benefits of poziotinib did not outweigh its risks.
Also check out: Why Fear Level Among US Investors Is Increasing
Commodities
In commodity news, oil traded down 5.7% to $78.75, while gold traded down 1.8% at $1,651.10.
Silver traded down 4% to $18.825 on Friday while copper fell 3.8% to $3.3410.
Euro zone
European shares closed lower today. The eurozone’s STOXX 600 fell 2.34%, London’s FTSE 100 fell 1.97% while Spain’s IBEX 35 Index fell 2.46%. The German DAX dropped 1.97%, French CAC 40 fell 2.28% and Italy’s FTSE MIB Index fell 3.36%.
The S&P Global Flash Eurozone services PMI declined to 48.9 in September from 49.8 in August, while manufacturing PMI slipped to 48.5 from 49.6. The S&P Global Flash Eurozone Composite PMI dropped to 48.2 in September from August’s reading of 48.9.
The S&P Global/CIPS UK manufacturing PMI climbed to 48.5 in September from 47.3 a month ago, while GfK consumer confidence indicator declined to -49 in September from -44 in the previous month. French composite PMI increased to 51.2 in September versus a 17-month low level of 50.4 in August, while German composite PMI declined to 45.9 from 46.9 in August. Spanish quarterly economic growth accelerated to 1.5% in the second quarter versus a preliminary reading of 1.1%.
Economics
- The S&P Global services PMI climbed to 49.2 in September from 43.7 in the prior month, while manufacturing PMI rose to 51.8 in September from 51.5 in August.
- The total number of active U.S. oil rigs climbed by 3 to 602 rigs this week, Baker Hughes Inc reported.
Check out this:
US Stocks Settle Lower For Third Consecutive Session Amid Low Volatility
COVID-19 Update
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 97,795,720 cases with around 1,080,830 deaths. India confirmed a total of at least 44,558,420 cases and 528,440 deaths, while France reported over 35,050,130 COVID-19 cases with 154,850 deaths. In total, there were at least 619,319,370 cases of COVID-19 worldwide with more than 6,537,030 deaths.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.